3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Brain Neoplasms
12
Cognitive Dysfunction
4
Radiation Injuries
3
Neoplasms
3
Multiple Myeloma
3
Glioma
3
Lymphoma, B-Cell
2
Lymphoma
2
Glioblastoma
2
Fatigue
2
Breast Neoplasms
2
Astrocytoma
2
Triple Negative Breast Neoplasms
1
Stroke
1
Sarcoma
1
Pituitary Neoplasms
1
Parkinson Disease
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Localized, Operable Non-small Cell Lung Cancer
1
Liver Neoplasms
1
Liver Diseases
1
Interventions
Radiotherapy
4
Paclitaxel
4
Carboplatin
4
Sodium Chloride
3
Oxaliplatin
3
Cyclophosphamide
3
Vincristine
2
Surveys and Questionnaires
2
Procarbazine
2
Prednisolone
2
Methotrexate
2
Mental Status and Dementia Tests
2
Magnetic Resonance Spectroscopy
2
Magnesium Sulfate
2
Leucovorin
2
Duloxetine Hydrochloride
2
Doxorubicin
2
Dexamethasone
2
Cytarabine
2
Calcium Gluconate
2
Amifostine
2
Acupuncture Therapy
2
neurotropin
1
motexafin gadolinium
1
haloperidol decanoate
1
glutamic acid diethyl ester
1
glucarpidase
1
fludarabine phosphate
1
fludarabine
1
axicabtagene ciloleucel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neurotoxicity Syndromes
×
Neuropsychological Tests
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled